The role of heat shock protein 27 expression in hepatocellular carcinoma in Japan: Special reference to the difference between hepatitis B and C

Liver International

Volumn 24, Issue 4, 2004, Pages 316-321

  Harimoto, Norifumi ^a   Shimada, Mitsuo ^a   Aishima, Shin Ichi ^a   Kitagawa, Dai ^a   Itoh, Shinji ^a   Tsujita, Eiji ^a   Maehara, Shin Ichiro ^a   Taketomi, Akinobu ^a   Tanaka, Shinji ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Heat shock protein 27; Hepatitis; Hepatocellular carcinoma; Virus

Indexed keywords

HEAT SHOCK PROTEIN 27; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAPAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE;

EID: 4444251798     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0927.x     Document Type: Article

References (24)

1. Lindquist S, Craig E A. The heat-shock proteins. Annu Rev Genet 1988; 22: 631-77.
2. Morimoto R I, Tisseres A, Georgopolous C, eds. Stress Protein in Biology and Medicine. Cold Spring Harbor, NY: Old Spring Harbor Laboratory Press, 1990.
3. Schleisinger M J. Heat shock proteins. J Biol Chem 1990; 265: 12111-4.
4. Macario A J L, Conway de Macario E. Stress and molecular chaperones in disease. Int J Clin Lab Reb 2000; 30: 49-66.
5. Garrido C, Ottavi P, Fromentin A, Hammann A, Arrigo A P, Chauffert B. HSP27 as a mediator of confluence-dependent resistance to cell death induced by anticancer drugs. Cancer Res 1996; 56: 2446-51.
6. Nylandsted J, Brand Jattela M. Heat shock protein 70 is required for the survival of cancer cells. Ann NY Acad Sci 2000; 926: 122-5.
7. Cornford P A, Dodson A R, Parsons K F, Desmond A D, Woolfenden A, Fordham M. Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 2000; 60(24): 7099-105.
8. Conroy S E, Latchman D S. Do heat shock proteins have a role in breast cancer? Br J Cancer 1996; 74: 717-21.
9. King K L, Li A F, Chau G Y, Chi C W, Wu C W, Huang C L. Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 2000; 88: 2464-70.
10. Kawanishi K, Shiozaki H, Doki Y, Sakita I, Inoue M, Yano M. Prognostic significance of heat shock protein 27 and 70 in patients with squamous cell carcinoma of the esophagus. Cancer 1999; 85: 1649-57.
11. Tetu B, Lacasse B, Bouchard H - L, Lagace R, Huot J, Laudry J. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopathological and immunohistochemical study. Cancer Res 1992; 52: 2325-8.
12. Ungar D R, Hailat N, Strahler J R, Kuick R D, Garrett M B, Seeger R C. HSP27 expression in neuroblastoma: correlation with disease stage. J Natl Cancer Inst 1994; 86: 780-4.
13. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology 1991; 14(5): 802-5.
14. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227: 80-5.
15. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995; 22(1): 20-4.
16. Merican I, Guan R, Amarapuka D, Alexander M J, Chutaputti A, Chien R N. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15(12): 1356-61.
17. Charette S J, Landry J. The interaction of HSP27 with dax identifies a potential regulatory role of HSP27 in Fas-induced apoptosis. Ann NY Acad Sci 2000; 926: 120-31.
18. Strivastava P K, Menoret A, Basu S, Binder R J, McQuade K L. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 1998; 8: 657-65.
19. Strivastava P K, Maki R G. Stress-induced proteins in immune response to cancer. Curr Topics Microbiol Immunol 1991; 167: 109-23.
20. Scorsone K A, Zhou Y, Butel J S, Slagle B L. P53 mutation cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinoma from China. Cancer Res 1992; 52: 1635-8.
21. Dominguez-Malagon H, Garaham S. Hepatocellular carcinoma: an update. Ultrastuct Pathol 2001; 25(6): 497-516.
22. Jeng K S, Sheen I S, Chen B F, Wu J Y. Is the p53 gene mutation of prognostic value in hepatocellular carcinoma after resection? Arch Surg 2000; 135(11): 1329-33.
23. Hayashi H, Sugio K, Matsumata T, Adachi E, Takenaka K, Sugimachi K. The clinical significance of p53 gene mutation in hepatocellular carcinoma. Hepatology 1995; 22: 1702-7.
24. Finlay C A, Hinds P W, Tan T H, Eliyahu D, Oren M, Levine A J. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70-p53 complex with altered half life. Mol Cell Biol 1988; 8: 531-9.